chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Rash began 2 days post vaccination on the fingers and spread to arms and legs and feet over 1 week.  Rash still present  6/14/2021.
Approximately 22 hours after I received the first vaccine my left arm from the elbow down to my hand went numb.  No tingling  just no feeling. Could not hold anything and no strength in that arm and hand.
Pt started coughing, his voice got really high-pitched, and his face got red. Pt's airway was evaluated by APRN and she could tell that it was physically closing. Treatment included: First Epipen was injected IM; Second 25mg Benadryl was given; Third 125mg SoluMedrol was given; Last pt received Albuterol Nebulizer Treatment in office.
Mother called approximately 15 minutes after child received immunizations, to report that child had a "seizure". Child quickly gained consciousness.
Mild to moderate chills, body aches and muscle cramps.  Lasted about 5 hours.
Swelling at injection site on left leg. Knot the size of a quarter with a red spot the size of a dime in the center. Slight elevation in temperature, but not enough to be considered a true fever (99-100). After four days the knot is now the size of a nickle but the red spot is gone. Area is still extremely sensitive and causes pain when even slightly touched.
Subsequent to receiving the first and second doses of varicella virus vaccine live, one in 1998 and the other one approximately, May, 1999, the pts arm became swollen, red and itchy. The pt recovered within 2 days. The pt sought unspecified medical treatment. Additional information has been requested.
headache, nonproductive cough, chills, shortness of breath, body aches, nasal congestion, chest tightness, wheezing, sneezing, ear fullness starting 11/12/21
Initial information received on 26-Dec-2018 regarding an unsolicited valid non-serious case received from a nurse. This case involves an eight-years-old patient of unknown gender who received vaccine FLUBLOK QIV. The patient's past medical history, medical treatment(s), vaccination(s), family history and concomitant therapy were not provided. On an unknown date, the patient received a dose of suspect Influenza Quadrivalent Recombinant Vaccine lot number not reported via unknown route in unknown administration site. It was a case of actual medication error due to inappropriate age at vaccine administration. It was reported by mother that her 2 children got vaccinated 3 or 4 days ago out of the same "package" - one was 18 and one was 8 years of age. She wasn't sure if the shot given was FLUBLOK or FLUZONE QUADRIVALENT. It was unknown whether adverse event occurred. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. List of documents held by sender: none.
Upper Deltoid on-going pain for three weeks continuous.  Limited movement and range of motion for shoulder.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 26-APR-2016, the patient was vaccinated with an improperly stored dose of GARDASIL 0.5 ml (lot # K011492, expiration date 22-JUN-2016). No adverse effects were reported. This specified lot number vaccine was exposed to temperature excursion three times. The total cumulative excursion time (hour), the lowest recorded temperature (Fahrenheit degree/Celsius) and the type of excursion (R/F) for each time were 24, 34 and R. The total cumulative excursion time (hour), the highest recorded temperature (Fahrenheit degree/Celsius) and the type of excursion (R/F) for each time were 176, 48 and R; 48, 47 and R. The storage criteria was refrigerator (R). This is one of several reports received from the same source. Additional information has been requested.
Patient complained of chills, aching muscles, back pain, headache, muscles tightening up, eyes hurting, especially while watching TV, fever (not taken) - mom states, "It's less than 100 degrees F". Symptoms occurred the night following administration of vaccine - 12/06/2011. Advised to seek medical attention.
Fever, chills, severe muscles aches, headache that started the evening of the injections.  Not able to work the next day.
I got sick and I've been sick/deathly ill; I had swollen cartilage in my nose and lips; I had swollen cartilage in my nose and lips; This is a spontaneous report from a contactable consumer (patient). A 70-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number and expiry date not reported), via an unspecified route of administration, on an unspecified date (reported as last week) (at the age 70-year-old), as dose 1, single, for COVID-19 immunisation. The patient medical history was not reported. Concomitant medications included 2 autoimmune suppressants (unspecified) and tofacitinib citrate (XELJANZ XR). The patient stopped taking Xeljanz for a month because she got Covid shot and became deathly ill, got sick and have been sick. The patient had swollen cartilage in nose and lips. Patient was prescribed Xeljanz XR 11 mg. The patient was running low on medication and didn't want to start taking it again until after she received her second shot. The outcome for the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
she was given a pediatric dose undiluted of 0.3ml, md was call and patient is fine.
Had swelling 2.5 times the size of his opposite arm. Fever of 102 F with Tylenol on board. Exquisite pain in the affected injected arm. Physician diagnosed cellulitis in the injected arm.
side effect; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (side effect) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (side effect). At the time of the report, ADVERSE REACTION (side effect) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Patient tested positive for SARS-COV-2. Patient positive for SARS-COV-2 in 09/2020. Patient tested negative x4 in 12/2020. Patient arrived to our facility with complaints of SOB, acute HTN, feeling warm and perhaps diaphoretic. Found with elevated BP, tachycardia, and tachypnea, afebrile, oxygen saturation 96% on 2L. Chest Xray consistent with COPD.
ROUND RED CIRCLE ON ARM AT INJECTION SITE. FIRST APPEARED ON 2/2/2021.  DOES NOT HURT, ARM DOES SEEM SLIGHTLY SWOLLEN IN THAT SPOT,  SLIGHT ITCH
their arm hurt for days\ arm hurt (at injection site); This case was reported by a consumer via call center representative and described the occurrence of injection site pain in an unknown number of patients who received Men B NVS (Bexsero) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received Bexsero and Bexsero Pre-Filled Syringe Device. On an unknown date, unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was recovered/resolved.   It was unknown if the reporter considered the injection site pain to be related to Bexsero and Bexsero Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The reporter's son had the Bexsero shot and she reports that, some of his friends got Bexsero and everybody said their arm hurt for days. No further information was known. This case has been linked to the case US2021160393, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021160393:Same reporter
Patient stated the night after receiving vaccine, she had a sore arm which was also red and warm. She slept that night and woke up to a swollen face and tongue. She stated it was hard to speak and swallow. Patient stated they took Benadryl for her reaction. Patient reported her reaction had settled by 3/6/21
Hospitalized Acute hypoxemic respiratory failure with COVID-19 pneumonia Dexamethasone (started 10/15), remdesivir (started 10/15), baracitinib (started 10/16)
Shot 10am 8/4-by 8:30pm that eve, abdominal pains-(R) side. Woke up 11:30pm same nite - pains so fierce thought I may have to go to ER. Severe flu symptoms - vomiting / diahrea 11:30 to 3:30am with abdominal pains, subsided by 4am very week Weds 8/5 & thurs 86 also, difficulty walking Also, severe pain @ injection site 8/4 until Fri pm 8/7/20. - No fever/no headache Note: I received Zoztovax vaccine 2011 no adverse reactions
83yo female resident who died after receiving Pfizer BioNTech vaccine.  On 1/14/2021, the patient reportedly got up in the middle of the night with c/o feeling "blah", restlessness, and nausea.  VS normal, no other s/sx. At 4:15am,  the patient was asked to go back to bed, assisted by a nurse and GNA.  At 6am, GNA was going to do morning VS and found the patient unresponsive, no pulse, no respirations.  GNA notified the nurse. At 6:03am, CPR started and EMS called.  At 6:15am, EMS arrived and took over.  At or around 6:30am, EMT called time of death
Patient received booster dose of original Moderna formulation rather than bivalent (NDC 80777-275-05). No adverse event reported.
Red itchy blotch at site approx 4 hrs (warm site). Itching all over approx 10 hrs until Benadryl took effect.
patient states that initially she had no issued other than a sore arm. 11 days after she received the vaccine the arm she received the vaccine in stated to itch. Patient states that she had been taking  Benadryl but arm is still itching. patient states that arm is red but that she doesn't notice an actual rash. Advised patient to contact her primary care doctor to notify him of reaction and for his recommendation of how she needs to treat it. Patient voiced understanding.
Pt received Janssen J&J vaccine lot 1808980 on May 26, 2021 and was sent to the 15 minute observation lot.  Pt then had a syncopal episode and hit the vehicle in front of her.  Zero damage noted.  Pt has hx of syncope with injections.  Pt was assessed by medics, vitals stable 88/62, HR 68, R 12, Skin: PWD.  Pt has no other s/sx.  Pt denies any other issues.  Pt states she feels fine now.  Pt's husband was called and he drove her home.  No further action needed.
Pt received the Anthrax vaccine on 08/29/2023 at 1030. Pt states that she sometimes has a hypersensitivity to vaccines in the past. Pt stated that she didn't have a reaction to previous dose of anthrax. Pt stated 15-20 minutes after vaccination  she started to feel nauseas. Pt states at 1215 she noticed a dropping sensation and swelling under her right eye. tingling on the right side of her lip and a strange sensation on the right side of her face. Pt stated that she came in to the clinic to see health care provider and started to feel a little light headed. Pt was recommended to go to the Emergency Room for further testing.
Patient received a 3rd dose of Moderna. 1st dose on 2/16/21, 2nd dose on 3/16/21, 3rd dose on 5/7/21.
Patient had tremors and was unable to walk for 15 minutes. This resolved and he felt normal afterward. When he called in on the next day (10/01/2020) he had no further symptoms.
Pt recv vax on 9/13/96; on 12/16/98 pt exp varicella rash
Administered Expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered Expired vaccine) in a 37-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered Expired vaccine). On 05-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administered Expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported.  The vaccine was stored in freezer and took one or two vials and placed in freezer each day as needed.
CHILLS; LOW GRADE FEVER; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported, per procedure no follow up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced chills, and low grade fever. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the chills and low grade fever was not reported. This report was non-serious.
This spontaneous report was received from a pharmacist, concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions, drug reactions, allergies, and concomitant medications were not reported. The pharmacist reported that on 23-JAN-2018, the patient was vaccinated with an expired dose of PNEUMOVAX 23 for prophylaxis, lot number M029681 and expiration date 22-JAN-2018 (strength, dose and route of administration were not reported). No adverse effects were reported.
Headache, Myalgia, Arthralgia, Fever,  stomach ache, chills Narrative: flu like symptoms
Nausea, vomiting and diarrhea 48-72 hours after administration of the vaccine. Unknown whether this was the result of the vaccination or something else. The patient was frail, had underlying heart conditions and died of a cardiac event which likely was related to dehydration sustained from these symptoms.
Patient presented today stating her school advised her she needed the 3rd Hep B in vaccine series.  Staff looked at shot record and only noted 2 hep B vaccines and vaccine was given.  However, when care manager re-examined the vaccine record it was noted that the series was complete and patient did not need another vaccine.  The dose that was given today was not needed.  The patient was monitored in clinic for 30 mins post injection with no adverse reactions noted.
No adverse event; Primary series: 2nd dose was administered >36 days after the first dose.; This spontaneous case was reported by a patient and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Primary series: 2nd dose was administered >36 days after the first dose.) and NO ADVERSE EVENT (No adverse event) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011J20A, 029L20A, 014C21A and 065K21A) for COVID-19 prophylaxis.     It was reported that patent did not receive any other vaccines in the 4 weeks prior to COVID-19 vaccine.    On 09-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Jan-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Primary series: 2nd dose was administered >36 days after the first dose.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Primary series: 2nd dose was administered >36 days after the first dose.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Primary series: 2nd dose was administered >36 days after the first dose.).    No concomitant medications was provided. No treatment medications was provided.   This case was linked to MOD-2023-719120 (Patient Link).
15 hours after dose 2, lightheaded.; Left arm pain for both doses.; Breast pain since dose 1; continued inflammation since dose 1; 15 hours after dose 2, sudden muscle pain; 15 hours after dose 2, sudden bone pain; 15 hours after dose 2, nauseous; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 25 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 02Aug2021 15:30 (Lot number: FA7484) at the age of 25 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: DIZZINESS (non-serious) with onset 03Aug2021, outcome "recovering", described as "15 hours after dose 2, lightheaded."; PAIN IN EXTREMITY (non-serious) with onset 03Aug2021, outcome "recovering", described as "Left arm pain for both doses."; BREAST PAIN (non-serious) with onset 03Aug2021, outcome "recovering", described as "Breast pain since dose 1"; INFLAMMATION (non-serious) with onset 03Aug2021, outcome "recovering", described as "continued inflammation since dose 1"; MYALGIA (non-serious) with onset 03Aug2021, outcome "recovering", described as "15 hours after dose 2, sudden muscle pain"; BONE PAIN (non-serious) with onset 03Aug2021, outcome "recovering", described as "15 hours after dose 2, sudden bone pain"; NAUSEA (non-serious) with onset 03Aug2021, outcome "recovering", described as "15 hours after dose 2, nauseous". Therapeutic measures were not taken as a result of dizziness, pain in extremity, breast pain, inflammation, myalgia, bone pain, nausea.  Additional information: The vaccine was administered in a pharmacy. The patient did not have any other vaccine in four weeks. The patient did not have covid prior to vaccination nor was tested since vaccination. The patient had no known allergies.   Follow-up attempts are completed. No further information is expected.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) in a 23-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Apr-2021 at 11:34 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 29-Apr-2021 at 11:34 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 23.73. Concomitant products were not provided. On 29-Apr-2021, Excursion time was 10 AM, temperature was 33, total doses given for the day was 201, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 19-Apr-2021, vial was moved to clinic on 29-Apr-2021. 5 vials were sent to clinic. Vaccine BUD date was 19-May-2021. On 29-Apr-2021, vials were stored in cooler 1, at following time and temperature respectively, 8 AM: not provided, 9 AM: 36, 10 AM: 33, 11 AM: 44, 12 AM: 45, 1PM: 45, 2 PM: 44, 3 PM: 45, 4 PM: 44 and 5 PM: not provided. The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic. Temperature recordings were taken using a brand traceable temperature monitor at every hour. After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature. It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F. Treatment medications were not reported.
Persisted for three days: Arm soreness Headaches Body Aches Tiredness/fatigue These faded and on 4/7/2020, liver began to feel enlarged for two days. This was followed by UTI; pain in kidneys and groin; rigidity, discoloration, and extreme swelling in right testicle; inability to urinate; 100-degree fever.  Remains on antibiotic (Keflex 500mg 4/pd) and Flomax. Testicle rigidity & some swelling remain.
Arm super sore; that night I a was miserable - fever, chills - sweats back and forth; nausea; diarrhea; intense headache - felt like head was going to explode; a little vomiting; neck and joint pain. Thursday around noon most of symptoms resolved - 1st meal I could eat without throwing it back up. Worst of neck pain was Tuesday night and Wednesday morning.  Neck pain (from having injuries and being a physical therapist - I was use to pain but this pain was extraordinary).Thursday morning - my back pain was so severe I could hardly walk. It hurt too bad to stand up. Neck is still mildly irritated but it is resolving.. Mild fatigue and upset stomach today. Treated during the course of symptoms - Tylenol - 2 pills every six hours. Topical over the counter anesthetics and CBD lotion/essential. Took pepto Bismul and Imodium but that didn't help stomach discomfort. Mostly recovered, but a little lingering symptoms today still.
Client received Johnson & Johnson vaccine and during the 15 minute post vaccination waiting period she had diaphoresis, lightheadedness, shortness of breath, tears in her eyes. She stated that she has had vasovagal reactions in the past. Vital signs : BP 78/58 p 87. Client is on doxycycline for Lupus, client was placed laying down on a cot. 911 was called, They arrived and performed an EKG and evaluated the client. Client sat up at 11:17 am and stated that "I'm starting to feel better." At 11:27 am client was feeling much better, client and EMT personnel determined that she did not needed to be transported to the hospital.